Li Ling Tan
Li Ling Tan publishes mostly in Cardiology and Cardiovascular Medicine, Oncology and Pulmonary and Respiratory Medicine, on topics such as Chemotherapy-induced cardiotoxicity and mitigation, Heart Failure Treatment and Management and Acute Myocardial Infarction Research.
- World rank
- #2,146,693 of 7,710,434 ranked researchers
- Rank in Singapore
- #10,638 of 23,642
- Works
- 39
- Citations
- 1.4k
- Citations per work
- 35.0
What does Li Ling Tan research?
Li Ling Tan's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1948.7%
- Health Sciences1845.9%
- Medicine1845.9%
- Life Sciences25.4%
- 1Cardiology and Cardiovascular Medicine23% of their works
- 2Oncology8% of their works
- 3Pulmonary and Respiratory Medicine6% of their works
- 4Molecular Biology5% of their works
- 5Epidemiology4% of their works
- 6Emergency Medicine4% of their works
Research topics
- Chemotherapy-induced cardiotoxicity and mitigation
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
- Acute Ischemic Stroke Management
- Lung Cancer Research Studies
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Neuroinflammation and Neurodegeneration Mechanisms
- Cardiovascular Function and Risk Factors
Which keywords describe Li Ling Tan's research?
The keywords of their largest research topics: Chemotherapy, Anthracyclines, Doxorubicin, Diagnosis, Guidelines, Heart Failure, Global Burden and B-Type Natriuretic Peptide.
- Neuroinflammation
- Echocardiography
- spirometry
- Small-Cell Lung Cancer
- Genomic Profiles
- COPD
- Treatment
- B-Type Natriuretic Peptide
- Heart Failure
- Diagnosis
- Anthracyclines
- Chemotherapy
- Doxorubicin
- Guidelines
- Global Burden
- Ischemic Stroke
- Acute Coronary Syndromes
- Endovascular Therapy
- Myocardial Infarction
- Thrombolysis
- Chamber Quantification
- Microglia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Chemotherapy132 topics
- Anthracyclines101 topic
- Doxorubicin101 topic
- Diagnosis82 topics
- Guidelines82 topics
- Heart Failure72 topics
- Global Burden62 topics
- B-Type Natriuretic Peptide51 topic
- Ischemic Stroke52 topics
- Treatment51 topic
- Acute Coronary Syndromes31 topic
- COPD31 topic
- Endovascular Therapy31 topic
- Genomic Profiles31 topic
- Myocardial Infarction31 topic
- Small-Cell Lung Cancer31 topic
- Thrombolysis31 topic
- spirometry31 topic
- Chamber Quantification21 topic
- Echocardiography21 topic
- Microglia21 topic
- Neuroinflammation21 topic
Where does Li Ling Tan work?
Li Ling Tan's main affiliation in the publication record is National University Heart Centre Singapore, Singapore.
How many publications and citations does Li Ling Tan have?
OpenAlex counts 39 works and 1,365 citations for Li Ling Tan, an h-index of 12, ranking #2,146,693 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Li Ling Tan
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Li Ling Tan. Posts are plain text and can be reported.